Psychiatric patients are sometimes given fact sheets about their treatment but the benefits of these are uncertain.
INTRODUCTION
The Royal College of Psychiatrists has produced several fact sheets covering major psychiatric treatments I but the benefits of such educational material are uncertain. Robinson et aI.2 found that fact sheets given to general psychiatric patients, with or without an interactive session with a professional, led to increases in knowledge immediately after the intervention. By contrast, Seltzer et al. 3 found no change in knowledge in a group of inpatients 5 months after a series of nine lectures based on medication fact sheets, though patients given education did show less fear of addiction and side-effects. Le Bas" advocated further evaluation of fact sheets. In the present study we aimed to investigate the educational benefits of two different methods of administering fact sheets to patients in general psychiatric wards.
METHOD
Patients were recruited from three adult psychiatric wards in a Bristol general hospital. All patients aged 18-75 who were taking psychotropic medication and had been in hospital for less than 6 weeks were invited to participate in the study. Patients degenerative brain disease or were considered by the nurse in charge to be too ill to participate, Fact sheets were designed by the authors and were broadly based on those prepared for the Royal College of Psychiatrists. Information was divided into three sections covering drug action, side-effects and precautions required when taking the medication. Four groups of psychotropic medication (antipsychotics, antidepressants, minor tranquil-Iizers and lithium) were included, and the corresponding fact sheets were written in the same question-and-answer format, ensuring uniformity and consistency in the method of delivery, if not the content of the information. Knowledge about medication was assessed by means of a semi-structured interview, the Knowledge of Medication Questionnaire (KMQ). This covered the three sections of 'drug action', 'side-effects' and 'precautions', generating three scores with a combined maximum of 13. Factual errors were separately recorded and cues were used to facilitate recall.
Patients were recruited from three admission cohorts meeting the above criteria. Consenting patients were given a semi-structured interview covering personal details, educational achievement (grouped as: no qualifications, GCSE equivalents, 'A' levels/HND, higher education), medication and insight. Insight and attitude to the chosen treatment were assessed by three simple questions: 'Do you have a psychiatric illness?'; 'Do you feel you need medication?'; 'Do you feel this is the right medication?'. Patients then completed the KMQ and were told that further interviews Table 2 Insight and attitUdes to treatment by patient group anorexia (1) and personality disorder (1). Thus, data from 33 patients (43% of all those qualifying) were used for analysis-I 0 patients in the control (C) group, 11 patients in the fact sheet (FS) group and 12 patients in the fact sheet+prompt (FS+) group. Sex, diagnostic group and educational background were evenly distributed between the three groups ( Table 1 ). The mean age for the whole sample was 43.4 years (range 22-74, standard deviation 13.8) and the mean total number of prescribed drugs was 2.8 per patient (standard deviation 1.8). Table 2 shows the breakdown of responses to the questions on insight and attitude to treatment. It is noteworthy that most of the patients in the FS+ group fclt that they were taking the right medication. Only five factual errors in total were recorded during the study and there were no differences in error scores between test and would be performed. After one week they were reinterviewed with the KMQ. At no point were they shown the fact sheet or given any information about medication. These patients represented the control group. Six weeks later, a second cohort was identified and approached. The researchers carried out the same procedure as for the first cohort but, after administering the KMQ, invited each patient to choose one from amongst their prescribed drugs to learn more about. They were then handed the fact sheet for the group of drugs to which the index drug belonged. The patient was asked to read the fact sheet and was told that further interviews could be performed after I week. These patients comprised the 'fact sheet group' . The third cohort was identified and approached a further 6 weeks later. The procedure was similar but supplemented by the researcher reading aloud the fact sheet with the patient and answering questions relating to it on two occasions in the first half of that week. This constituted the 'fact sheet+prompt group'. In this way, patients were randomly assigned to control and study groups according to their admission date.
Other clinical information was obtained from the ward psychiatrist including diagnosis, current prescribed medication and duration of treatment with the index drug. Also, the patient's mental state was rated during both periods of testing as demonstrating 'active symptoms', 'residual symptoms' or 'no symptoms'. All patients were asked whether they wanted more information about the index drug and those who had received fact sheets were asked whether they had read them and whether they had found them useful.
Data were analysed by use of the Statistical Package for Social Sciences (SPSS). Where distribution of scores was skewed, data were analysed by non-parametric statistics.
RESULTS
Seventy-seven patients fulfilled the inclusion criteria, of whom six were judged too ill to participate (usual reason being too psychotically disturbed), 11 refused to participate (usual reasons being lack of interest or hostility), 10 were persistently absent from the ward (usual reason being 'on leave') and two were discharged before they could be retested. The remaining 48 completed the study, representing 62% of those qualifying for inclusion. However, patients diagnosed as having mania (4), schizophrenia (9) or organic states (2) were not evenly distributed amongst the 'control', 'fact sheet' and 'fact sheet+prompt' groups and were excluded from analysis. Patients with the remaining diagnoses of neurotic depression (10), psychotic depression (11) or 'other' (12) were evenly distributed. The 'other' category consisted of a mixture of acute anxiety state (5), drug or alcohol withdrawal (3), paranoid psychosis (2), retest. On first testing, 73% of patients were assessed as having active or residual symptoms whilst on retest the corresponding figure was 79%.
Attitudes to fact sheets and current treatment
Of the 23 patients in the FS and FS+ groups who received fact sheets after initial testing, 18 (78%) had been taking the index drug for less than I year. After the intervention 20 (87%) said that they had independently read the fact sheet and 18 (78%) reported finding it helpful whilst all 23 (100%) said they would like more information. 
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Scores on the Knowledge of Medication Questionnaire
By Kruskal-Wallis one-way analysis of variance (ANaYA), there were no between-group differences in total scores of baseline knowledge: mean baseline KMQ scores for C, FS and FS+ groups were 3.90 (SO 2.23, range 1-8,),4.27 (SO 2.15, range 1-9) and 5.50 (SO 2.15, range 2--9), respectively. Moreover, there were no differences in mean action scores, precautions scores, or side-effects scores. Figure I shows the change in KMQ scores between test and retest for each of the groups. There were significant differences in change scores between the three groups (Kruskal--Wallis one-way ANaYA df2, 8.86, P=O.OI). However, when assessed separately hy the Mann-Whitney U test, the difference between the C and FS groups was not significant (Z= -1.28, corrected P=0.20), the difference between FS and FS+groups was significant (Z= -2.07, corrected P=0.04) and the difference between C and FS+ was highly significant (£=-2.70, corrected P<O.OI). When the difference between test and retest scores for individual subscalcs was considered in the three groups, a significant increase in knowledge was found in the 'sideeffects' subscale, a non-significant trend towards increased knowledge was found in the 'precautions' subscalc, but no substantial change was demonstrated in the 'drug action' subscale (Kruskal-Wallis, one-way ANaYA corrected for tics, df2, 6.8, P=0.03, 5.S, P=0.06, and 2.2, P=0.32, respectively).
DISCUSSION
Patients have the right to be involved in decision-making about which drugs they ingest and to be informed about drug actions and side-effects. Allied to these ethical imperatives are medico-legal considerations; if doctors are not active in providing such information they risk being sued in the courts. Furthermore, getting patients to understand their medication can improve their compliance 3 . This study has several weaknesses. Only 48 of the 77 eligible patients (62.3%) completed the study and their random allocation to control, fact sheet, and fact sheet+prompt groups produced a skewed distribution with respect to the diagnoses 'schizophrenia', 'mania' and 'organic states'. It is difficult to know how the 15 patients with these diagnoses who had to be excluded would have responded to education. Therefore, these results cannot be extrapolated to a wider general psychiatric population. Patients with schizophrenia may not learn facts in the same way as those with depression or anxiety states. Also, the 1 week follow-up period may not be a good indicator of the long-term retention and recall of information. Since the ability to recall information wanes over time, further education sessions may be necessary to ensure that patients stay informed about their treatments. The main strength of the study is that the two experimental groups were compared with a control group and, in addition, each patient acted as his or her own control. This would have minimized the effect of extraneous learning about medication.
These results indicate that handing out medication fact sheets alone does not improve patients' knowledge of their medication, but knowledge does increase if this is backed up by a health professional reading them through, explaining them, and answering related questions. Interaction with health professionals is a vital component of patient education, as previously demonstrated by Robinson et al.2. Patients in our study selectively learned most about the side-effects of medication-a finding which is in accordance with the work of Soskis et aI.5 who found that psychiatric inpatients knew most about side-effects whereas medical inpatients knew most about the therapeutic action of their medication. The discrepancy in learning about different aspects of medication information may relate to a perception among psychiatric patients that their medication is not necessary or helpful and a general reluctance to engage in treatment. Psychiatric illness is often associated with lack of insight (although this was not a major factor amongst our patients).
Pre-existing knowledge does not seem to have been a major factor in determining learning about medication since there were no differences between the scores of the three groups on first testing. Furthermore, the differential learning observed in the study does not seem to be explicable in terms of educational achievement or insight. With regard to patient attitude, the fact that most patients in the SF+group thought they were on the right medication may have increased their motivation to learn more about it. Since all patients receiving the fact sheets said they would like more information, it may be that giving some information sparks off further interest and offers the possibility of engaging the patient further in the treatment programme.
This intervention is brief, simple, easily administered and could be taught to ward nurses. The results seem clinically relevant and should encourage wider use of educational material as well as further attempts to evaluate the health and economic benefits. The study needs to be replicated in different treatment settings, either with a larger sample of patients or with a single diagnostic category.
Note Examples of the medication fact sheets and Knowledge of Medication Questionnaires are available from the authors.
